Streetbeat News

Analyst Ratings

AMGN

Argus Research has maintained its Buy rating on Amgen (NASDAQ:AMGN) and raised the price target from $300 to $340, indicating a positive outlook for the stock.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:47 pm

LEN

Argus Research has maintained its Buy rating on Lennar (NYSE:LEN) and raised the price target from $175 to $180.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:46 pm

EXAS

BTIG analyst Mark Massaro maintains a Buy rating on Exact Sciences (NASDAQ:EXAS) but lowers the price target from $80 to $70.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:43 pm

RIO

Berenberg analyst Richard Hatch has downgraded Rio Tinto (NYSE:RIO) from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:41 pm

GRND

TD Cowen analyst Floris Van Dijkum maintains a Buy rating on Grindr (NYSE:GRND) and raises the price target from $12 to $14.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:37 pm

SIRI

Guggenheim analyst Curry Baker maintains a Neutral rating on Sirius XM Holdings (NASDAQ:SIRI) but lowers the price target from $3.3 to $2.9.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:33 pm

SPHR

Guggenheim analyst Ian Zaffino maintains a Buy rating on Sphere Entertainment (NYSE:SPHR) but lowers the price target from $48 to $43.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:31 pm

COR

Leerink Partners analyst Michael Cherny maintains an Outperform rating on Cencora (NYSE:COR) with a $275 price target.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:31 pm

SVRA

Guggenheim analyst Daniel Krizay maintains a Buy rating on Savara (NASDAQ:SVRA) and raises the price target from $8 to $10.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:29 pm

LYEL

B of A Securities analyst Geoff Meacham maintains a Buy rating on Lyell Immunopharma (NASDAQ:LYEL) but lowers the price target from $9 to $6.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 5:28 pm